Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $368.18 million. The enterprise value is $383.19 million.
| Market Cap | 368.18M |
| Enterprise Value | 383.19M |
Important Dates
The next confirmed earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 131.96 million shares outstanding. The number of shares has increased by 0.27% in one year.
| Shares Outstanding | 131.96M |
| Shares Change (YoY) | +0.27% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 33.32% |
| Owned by Institutions (%) | 44.96% |
| Float | 61.84M |
Valuation Ratios
The trailing PE ratio is 69.75 and the forward PE ratio is 12.32.
| PE Ratio | 69.75 |
| Forward PE | 12.32 |
| PS Ratio | 0.85 |
| Forward PS | 0.80 |
| PB Ratio | 1.32 |
| P/FCF Ratio | 56.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.64, with an EV/FCF ratio of 58.48.
| EV / Earnings | 77.49 |
| EV / Sales | 0.88 |
| EV / EBITDA | 10.64 |
| EV / EBIT | 30.46 |
| EV / FCF | 58.48 |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.43.
| Current Ratio | 2.80 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 3.31 |
| Debt / FCF | 18.21 |
| Interest Coverage | 5.75 |
Financial Efficiency
Return on equity (ROE) is 1.80% and return on invested capital (ROIC) is 1.50%.
| Return on Equity (ROE) | 1.80% |
| Return on Assets (ROA) | 1.10% |
| Return on Capital (ROIC) | 1.50% |
| Revenue Per Employee | $502,483 |
| Profits Per Employee | $5,737 |
| Employee Count | 862 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 4.02 |
Taxes
In the past 12 months, ORGO has paid $5.45 million in taxes.
| Income Tax | 5.45M |
| Effective Tax Rate | 52.42% |
Stock Price Statistics
The stock price has increased by +35.44% in the last 52 weeks. The beta is 1.57, so ORGO's price volatility has been higher than the market average.
| Beta (1Y) | 1.57 |
| 52-Week Price Change | +35.44% |
| 50-Day Moving Average | 3.08 |
| 200-Day Moving Average | 3.10 |
| Relative Strength Index (RSI) | 45.43 |
| Average Volume (30 Days) | 733,832 |
Short Selling Information
The latest short interest is 7.23 million, so 5.48% of the outstanding shares have been sold short.
| Short Interest | 7.23M |
| Short Previous Month | 8.01M |
| Short % of Shares Out | 5.48% |
| Short % of Float | 11.69% |
| Short Ratio (days to cover) | 9.31 |
Income Statement
In the last 12 months, ORGO had revenue of $433.14 million and earned $4.95 million in profits. Earnings per share was $0.04.
| Revenue | 433.14M |
| Gross Profit | 326.66M |
| Operating Income | 12.53M |
| Pretax Income | 10.39M |
| Net Income | 4.95M |
| EBITDA | 36.03M |
| EBIT | 12.58M |
| Earnings Per Share (EPS) | $0.04 |
Balance Sheet
The company has $104.34 million in cash and $119.35 million in debt, giving a net cash position of -$15.01 million or -$0.11 per share.
| Cash & Cash Equivalents | 104.34M |
| Total Debt | 119.35M |
| Net Cash | -15.01M |
| Net Cash Per Share | -$0.11 |
| Equity / Book Value | 278.66M |
| Book Value Per Share | 2.11 |
| Working Capital | 144.54M |
Cash Flow
In the last 12 months, operating cash flow was $30.92 million and capital expenditures -$24.36 million, giving a free cash flow of $6.55 million.
| Operating Cash Flow | 30.92M |
| Capital Expenditures | -24.36M |
| Free Cash Flow | 6.55M |
| FCF Per Share | $0.05 |
Margins
Gross margin is 75.42%, with operating and profit margins of 2.89% and 1.14%.
| Gross Margin | 75.42% |
| Operating Margin | 2.89% |
| Pretax Margin | 2.40% |
| Profit Margin | 1.14% |
| EBITDA Margin | 8.32% |
| EBIT Margin | 2.90% |
| FCF Margin | 1.51% |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.27% |
| Shareholder Yield | -0.27% |
| Earnings Yield | 1.34% |
| FCF Yield | 1.78% |
Analyst Forecast
The average price target for ORGO is $4.83, which is 73.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.83 |
| Price Target Difference | 73.12% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 2.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.5 |
| Piotroski F-Score | 5 |